<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37042019</PMID><DateCompleted><Year>2023</Year><Month>04</Month><Day>13</Day></DateCompleted><DateRevised><Year>2023</Year><Month>04</Month><Day>21</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1555-8584</ISSN><JournalIssue CitedMedium="Internet"><Volume>20</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Jan</Month></PubDate></JournalIssue><Title>RNA biology</Title><ISOAbbreviation>RNA Biol</ISOAbbreviation></Journal><ArticleTitle>L1CAM immunocapture generates a unique extracellular vesicle population with a reproducible miRNA fingerprint.</ArticleTitle><Pagination><StartPage>140</StartPage><EndPage>148</EndPage><MedlinePgn>140-148</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1080/15476286.2023.2198805</ELocationID><Abstract><AbstractText>Micro RNAs (miRNAs) are short, non-coding RNAs with significant potential as diagnostic and prognostic biomarkers. However, a lack of reproducibility across studies has hindered their introduction into clinical settings. Inconsistencies between studies include a lack of consensus on the miRNAs associated with a specific disease and the direction of regulation. These differences may reflect the heterogenous nature of pathologies with multiple phenotypes, such as amyotrophic lateral sclerosis (ALS). It is also possible that discrepancies are due to different sampling, processing, and analysis protocols across labs. Using miRNA extracted from L1CAM immunoaffinity purified extracellular vesicles (neural-enriched extracellular vesicles or NEE), we thrice replicated an 8-miRNA fingerprint diagnostic of ALS, which includes the miRNA species and direction of regulation. We aimed to determine if the extra purification steps required to generate NEE created a unique extracellular vesicle (EV) fraction that might contribute to the robustness and replicability of our assay. We compared three fractions from control human plasma: 1) total heterogenous EVs (T), 2) L1CAM/neural enriched EVs (NEE), and 3) the remaining total-minus-NEE fraction (T-N). Each fraction was characterized for size, total protein content, and protein markers, then total RNA was extracted, and qPCR was run on 20 miRNAs. We report that the miRNA expression within NEE was different enough compared to T and T-N to justify the extra steps required to generate this fraction. We conclude that L1CAM immunocapture generates a unique fraction of EVs that consistently and robustly replicates a miRNA fingerprint which differentiates ALS patients from controls.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Dunlop</LastName><ForeName>Rachael Anne</ForeName><Initials>RA</Initials><AffiliationInfo><Affiliation>Brain Chemistry Labs, Jackson, Wyoming, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Banack</LastName><ForeName>Sandra Anne</ForeName><Initials>SA</Initials><AffiliationInfo><Affiliation>Brain Chemistry Labs, Jackson, Wyoming, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cox</LastName><ForeName>Paul Alan</ForeName><Initials>PA</Initials><Identifier Source="ORCID">0000-0001-6401-2981</Identifier><AffiliationInfo><Affiliation>Brain Chemistry Labs, Jackson, Wyoming, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>RNA Biol</MedlineTA><NlmUniqueID>101235328</NlmUniqueID><ISSNLinking>1547-6286</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D035683">MicroRNAs</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D039842">Neural Cell Adhesion Molecule L1</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D035683" MajorTopicYN="Y">MicroRNAs</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D039842" MajorTopicYN="Y">Neural Cell Adhesion Molecule L1</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015203" MajorTopicYN="N">Reproducibility of Results</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000067128" MajorTopicYN="Y">Extracellular Vesicles</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Exosome</Keyword><Keyword MajorTopicYN="N">L1CAM</Keyword><Keyword MajorTopicYN="N">amyotrophic lateral sclerosis (ALS)</Keyword><Keyword MajorTopicYN="N">biomarker</Keyword><Keyword MajorTopicYN="N">neural-enriched</Keyword><Keyword MajorTopicYN="N">reproducibility</Keyword></KeywordList><CoiStatement>The not-for-profit research institute Brain Chemistry Labs has applied for a patent on the use of this biomarker.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>4</Month><Day>13</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>4</Month><Day>12</Day><Hour>1</Hour><Minute>52</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>4</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37042019</ArticleId><ArticleId IdType="pmc">PMC10101655</ArticleId><ArticleId IdType="doi">10.1080/15476286.2023.2198805</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Fabian MR, Sundermeier TR, Sonenberg N.. Understanding how miRnas post-transcriptionally regulate gene expression. Prog Mol Subcell Biol. 2010;50:1&#x2013;20.</Citation><ArticleIdList><ArticleId IdType="pubmed">19841878</ArticleId></ArticleIdList></Reference><Reference><Citation>Vasudevan S, Tong Y, Steitz JA. Cell cycle control of microRNA-mediated translation regulation. Cell Cycle Georget Tex. 2008;7:1545&#x2013;1549.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2556257</ArticleId><ArticleId IdType="pubmed">18469529</ArticleId></ArticleIdList></Reference><Reference><Citation>Th&#xe9;ry C, Witwer KW, Aikawa E, et al. Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the international society for extracellular vesicles and update of the MISEV2014 guidelines. J Extracell Vesicles. 2018;7(1):1535750. DOI:10.1080/20013078.2018.1535750</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/20013078.2018.1535750</ArticleId><ArticleId IdType="pmc">PMC6322352</ArticleId><ArticleId IdType="pubmed">30637094</ArticleId></ArticleIdList></Reference><Reference><Citation>Sardar Sinha M, Ansell-Schultz A, Civitelli L, et al. Alzheimer&#x2019;s disease pathology propagation by exosomes containing toxic amyloid-beta oligomers. Acta Neuropathol (Berl). 2018;136(1):41&#x2013;56. DOI:10.1007/s00401-018-1868-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-018-1868-1</ArticleId><ArticleId IdType="pmc">PMC6015111</ArticleId><ArticleId IdType="pubmed">29934873</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang M, Yu F, Ding H, et al. Emerging function and clinical values of exosomal MicroRNAs in cancer. Mol Ther Nucleic Acids. 2019;16:791&#x2013;804.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6545365</ArticleId><ArticleId IdType="pubmed">31163321</ArticleId></ArticleIdList></Reference><Reference><Citation>Banack SA, Dunlop RA, Stommel EW, et al. miRNA extracted from extracellular vesicles is a robust biomarker of amyotrophic lateral sclerosis. J Neurol Sci. 2022;442:120396.</Citation><ArticleIdList><ArticleId IdType="pubmed">36081303</ArticleId></ArticleIdList></Reference><Reference><Citation>Richards D, Morren JA, Pioro EP. Time to diagnosis and factors affecting diagnostic delay in amyotrophic lateral sclerosis. J Neurol Sci. 2020;417:117054.</Citation><ArticleIdList><ArticleId IdType="pubmed">32763509</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehta P, Antao V, Kaye W, et al. Prevalence of amyotrophic lateral sclerosis - United States, 2010-2011. MMWR. 2014;Suppl 63(7):1&#x2013;14.</Citation><ArticleIdList><ArticleId IdType="pubmed">25054277</ArticleId></ArticleIdList></Reference><Reference><Citation>Banack SA, Dunlop RA, Cox PA. An miRNA fingerprint using neural-enriched extracellular vesicles from blood plasma: towards a biomarker for amyotrophic lateral sclerosis/motor neuron disease. Open Biol. 2020;10(6). DOI:10.1098/rsob.200116</Citation><ArticleIdList><ArticleId IdType="doi">10.1098/rsob.200116</ArticleId><ArticleId IdType="pmc">PMC7333885</ArticleId><ArticleId IdType="pubmed">32574550</ArticleId></ArticleIdList></Reference><Reference><Citation>Mustapic M, Eitan E, Werner JK Jr, et al. Plasma Extracellular Vesicles enriched for neuronal origin: a potential window into brain pathologic processes. Front Neurosci. 2017;11:278.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5439289</ArticleId><ArticleId IdType="pubmed">28588440</ArticleId></ArticleIdList></Reference><Reference><Citation>Dunlop RA, Banack SA, Cox PA. A comparison of the efficiency of RNA extraction from extracellular vesicles using the Qiagen RNeasy MinElute versus Enzymax LLC RNA Tini Spin columns and qPCR of miRNA. Biol Methods Protoc. 2021;6(1):1&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8344526</ArticleId><ArticleId IdType="pubmed">34423131</ArticleId></ArticleIdList></Reference><Reference><Citation>Hellemans J, Mortier G, De Paepe A, et al. qBase relative quantification framework and software for management and automated analysis of real-time quantitative PCR data. Genome Biol. 2007;8(2):R19. DOI:10.1186/gb-2007-8-2-r19</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/gb-2007-8-2-r19</ArticleId><ArticleId IdType="pmc">PMC1852402</ArticleId><ArticleId IdType="pubmed">17291332</ArticleId></ArticleIdList></Reference><Reference><Citation>Vandesompele J, De Preter K, Pattyn F, et al. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol. 2002;3(7):RESEARCH0034. DOI:10.1186/gb-2002-3-7-research0034</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/gb-2002-3-7-research0034</ArticleId><ArticleId IdType="pmc">PMC126239</ArticleId><ArticleId IdType="pubmed">12184808</ArticleId></ArticleIdList></Reference><Reference><Citation>Pegtel DM, Gould SJ. Exosomes. Annu Rev Biochem. 2019;88(1):487&#x2013;514.</Citation><ArticleIdList><ArticleId IdType="pubmed">31220978</ArticleId></ArticleIdList></Reference><Reference><Citation>Matias-Garcia PR, Wilson R, Mussack V, et al. Impact of long-term storage and freeze-thawing on eight circulating microRnas in plasma samples. PLoS ONE. 2020;15:e0227648.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6959605</ArticleId><ArticleId IdType="pubmed">31935258</ArticleId></ArticleIdList></Reference><Reference><Citation>Blondal T, Jensby Nielsen S, Baker A, et al. Assessing sample and miRNA profile quality in serum and plasma or other biofluids. Methods. 2013;59:S1&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">23036329</ArticleId></ArticleIdList></Reference><Reference><Citation>Basso D, Padoan A, Laufer T, et al. Relevance of pre-analytical blood management on the emerging cardiovascular protein biomarkers TWEAK and HMGB1 and on miRNA serum and plasma profiling. Clin Biochem. 2017;50(4&#x2013;5):186&#x2013;193. DOI:10.1016/j.clinbiochem.2016.11.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clinbiochem.2016.11.005</ArticleId><ArticleId IdType="pubmed">27847340</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y, Gelfond JA, McManus LM, et al. Reproducibility of quantitative RT-PCR array in miRNA expression profiling and comparison with microarray analysis. BMC Genomics. 2009;10:407.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2753550</ArticleId><ArticleId IdType="pubmed">19715577</ArticleId></ArticleIdList></Reference><Reference><Citation>Godoy PM, Barczak AJ, DeHoff P, et al. Comparison of reproducibility, accuracy, sensitivity, and specificity of miRNA quantification platforms. Cell Rep. 2019;29(12):4212&#x2013;4222.e5. DOI:10.1016/j.celrep.2019.11.078</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2019.11.078</ArticleId><ArticleId IdType="pmc">PMC7499898</ArticleId><ArticleId IdType="pubmed">31851944</ArticleId></ArticleIdList></Reference><Reference><Citation>Witwer KW, Halushka MK. Toward the promise of microRnas &#x2013; Enhancing reproducibility and rigor in microRNA research. RNA Biol. 2016;13(11):1103&#x2013;1116.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5100345</ArticleId><ArticleId IdType="pubmed">27645402</ArticleId></ArticleIdList></Reference><Reference><Citation>Faissner A, Kruse J, Nieke J, et al. Expression of neural cell adhesion molecule L1 during development, in neurological mutants and in the peripheral nervous system. Brain Res. 1984;15(1):69&#x2013;82.</Citation><ArticleIdList><ArticleId IdType="pubmed">6467033</ArticleId></ArticleIdList></Reference><Reference><Citation>Faur&#xe9; J, Lachenal G, Court M, et al. Exosomes are released by cultured cortical neurones. Mol Cell Neurosci. 2006;31(4):642&#x2013;648. DOI:10.1016/j.mcn.2005.12.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mcn.2005.12.003</ArticleId><ArticleId IdType="pubmed">16446100</ArticleId></ArticleIdList></Reference><Reference><Citation>Maness PF, Schachner M. Neural recognition molecules of the immunoglobulin superfamily: signaling transducers of axon guidance and neuronal migration. Nat Neurosci. 2007;10(1):19&#x2013;26.</Citation><ArticleIdList><ArticleId IdType="pubmed">17189949</ArticleId></ArticleIdList></Reference><Reference><Citation>Rathjen FG, Schachner M. Immunocytological and biochemical characterization of a new neuronal cell surface component (L1 antigen) which is involved in cell adhesion. Embo J. 1984;3(1):1&#x2013;10.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC557289</ArticleId><ArticleId IdType="pubmed">6368220</ArticleId></ArticleIdList></Reference><Reference><Citation>Lachenal G, Pernet-Gallay K, Chivet M, et al. Release of exosomes from differentiated neurons and its regulation by synaptic glutamatergic activity. Mol Cell Neurosci. 2011;46(2):409&#x2013;418. DOI:10.1016/j.mcn.2010.11.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mcn.2010.11.004</ArticleId><ArticleId IdType="pubmed">21111824</ArticleId></ArticleIdList></Reference><Reference><Citation>Norman M, Ter-Ovanesyan D, Trieu W, et al. L1CAM is not associated with extracellular vesicles in human cerebrospinal fluid or plasma. Nat Methods. 2021;18(6):631&#x2013;634. DOI:10.1038/s41592-021-01174-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41592-021-01174-8</ArticleId><ArticleId IdType="pmc">PMC9075416</ArticleId><ArticleId IdType="pubmed">34092791</ArticleId></ArticleIdList></Reference><Reference><Citation>Kiefel H, Bondong S, Hazin J, et al. L1cam. Cell Adhes Migr. 2012;6(4):374&#x2013;384. DOI:10.4161/cam.20832</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/cam.20832</ArticleId><ArticleId IdType="pmc">PMC3478260</ArticleId><ArticleId IdType="pubmed">22796939</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>